All News
🟢 ARTY is trading 1.56% up in pre-market
ARTY is trading at $69.94, up 1.56% pre-market, with no new ARTY-specific announcement or clear catalyst identified for the move. - The prior-session...
🟢 Immix Biopharma is trading 8% up in pre-market with no clear company-specific catalyst
Immix Biopharma is trading at $9.00, up +7.78%, before the October 23, 2026 open, with no clear company-specific announcement tied to the move. - The latest...
Rithm Capital's third quarter 2026 revenue of $1.76B beat estimates while book value expanded
Rithm Capital reported third quarter 2026 results that exceeded top-line expectations, supported by scaling its alternative asset management platform and...
🔴 BioLineRx is trading 6.7% down in pre-market
BioLineRx is trading 6.7% down at $1.95 in pre-market, with no clear company-specific announcement identified as the reason. - The company’s...
Balchem Corporation reports record third quarter 2026 sales of $291M with growth in all segments
Balchem Corporation achieved record consolidated net sales and earnings for the third quarter of 2026, supported by organic growth across its entire portfolio....
Xencor's Kidney Cancer Drug Gets Its Biggest Test Yet — Can Early Data Justify a Stock That Has Already Doubled?
Shares surged +8.4% to $28.00 as Xencor's most important clinical catalyst arrived: early-stage trial results for its experimental kidney cancer drug, a...
🟢 Tech ETF (HUMN) is trading 13.53% up in pre-market; no verified overnight catalyst
HUMN is trading at $29.99 (+13.53%) in pre-market, with no verified overnight catalyst explaining the sharp rise. - Available sector news points the other...
🟢 BIO-key International is trading 14% up in pre-market after Gulf-region government institution selected PortalGuard IAM
BIO-key International is trading at $3.12, up 13.98%, after a Gulf-region government institution selected its PortalGuard IAM platform and biometric...
🔴 Mednax is trading 4% down in pre-market
Mednax is trading 4.3% lower at $28.27, compared with its October 22 close of $29.55. - The provided market backdrop is mildly negative but does not show a...
🟢 Xencor is trading 8.4% up in pre-market ahead of scheduled XmAb819 Phase 1 results
Xencor is trading at $28.00, up 8.36%, ahead of scheduled XmAb819 Phase 1 updates, though available coverage does not directly link the pre-market move to...
🔴 Verizon Communications is trading 4.1% down in pre-market after report SpaceX seeks U.S. cell-site access
Verizon Communications is trading 4.1% down at $43.37 after a report that SpaceX is seeking access to at least 80,000 U.S. cell sites. - Reuters reported...
🔴 GE HealthCare is trading 4.03% down in pre-market with no clear company-specific catalyst
GE HealthCare is trading at $68.50, down 4.03%, before the open on October 23; no clear company-specific catalyst has surfaced. - The October 22 close was...
🟢 Blaize Holdings is trading 9.35% up in pre-market with no clear catalyst identified
Blaize Holdings is trading at $0.27, up 9.35%, with no clear fresh catalyst identified for the October 23 pre-market gain. - The move is opposite the supplied...
🟢 BIO-key International is trading 8% up in pre-market after Gulf-region government institution selects PortalGuard
BIO-key International is trading at $2.95, up 7.66%, after announcing that a new Gulf-region government institution selected its PortalGuard identity platform...
🟢 Arcturus Therapeutics is trading 6% up in pre-market with no clear catalyst identified
Arcturus Therapeutics is trading at $11.38, up 6.06%, with no clear company-specific announcement or catalyst identified for October 23, 2026. - The stock is...
Alphatec Surges 10% on Heavy Volume Ahead of Earnings — But Can a Still-Unprofitable Spine Company Justify the Optimism?
Shares of Alphatec Holdings jumped 10% to $12.50 on Friday, blowing past a sluggish broader market on no identifiable company news. The catalyst: investors...
🟢 SUI Group is trading 7.6% up in pre-market with no clear catalyst identified
SUI Group is trading 7.6% up at $1.28 in pre-market on October 23, with no clear company-specific catalyst identified. - The prior session closed at $1.19. -...
🔴 Royalty Pharma is trading 4.3% down in pre-market with U.S. futures pointing lower
Royalty Pharma is trading 4.31% lower at $61.00, with no new company-specific announcement identified for October 23. - Supplied price context lists the...
🔴 Peraso is trading 6.6% down in pre-market amid semiconductor weakness after Lam Research’s outlook
Peraso is trading 6.6% down now at $0.37, with semiconductor weakness the stronger context for the October 23 pre-market decline. - No clear new...
🔴 Omnicell is trading 7% down in pre-market; catalyst remains unclear
Omnicell is trading 7.01% down at $34.50 before the October 23, 2026 open, versus the October 22 close of $37.10; no clear company-specific announcement...